(Q30577078)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Ichiro Nakashima

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Douglas Sato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jerome de Seze

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Anu Jacob

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Liene Elsone

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Kazuo Fujihara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

English

0 references

publication date

10 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neurology, Neurosurgery and Psychiatry

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

922-930

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

The spectrum of neuromyelitis optica

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

An epidemiological study of neuromyelitis optica in Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

A population-based study of neuromyelitis optica in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Neuromyelitis optica in France: a multicenter study of 125 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Familial neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Brain abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Clinical spectrum of CNS aquaporin-4 autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

CNS aquaporin-4 autoimmunity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Magnetic resonance spectroscopy evaluation in patients with neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Neuromyelitis optica: not a multiple sclerosis variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Myasthenia gravis-associated neuromyelitis optica-like disease: an immunological link between the central nervous system and muscle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

New insights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Structure and functions of aquaporin-4-based orthogonal arrays of particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Beneficial plasma exchange response in central nervous system inflammatory demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Interferon-β exacerbates Th17-mediated inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Treatment of neuromyelitis optica: current debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Failure of natalizumab to prevent relapses in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Neuromyelitis optica treatment: analysis of 36 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Relapsing neuromyelitis optica responsive to glatiramer acetate treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

A case of relapsing neuromyelitis optica treated with glatiramer acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Intermittent plasmapheresis prevents recurrence in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-302310

21 January 2018

Identifiers

DOI

10.1136/JNNP-2012-302310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23142960%20AND%20SRC:MED&resulttype=core&format=json

release_stnaep7odveuldb5eljgjpygre

17 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/stnaep7odveuldb5eljgjpygre

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference